Rowley Law PLLC is investigating potential securities law violations by Proteostasis Therapeutics, Inc. (NASDAQ: PTI) and its board of directors concerning the proposed acquisition of the company by Yumanity Therapeutics. Proteostasis Therapeutics stockholders will own approximately 32.5% of the combined company. The transaction is expected to close in the fourth quarter of 2020.

If you are a stockholder of Proteostasis Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/pti/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Shane Rowley, Esq. Rowley Law PLLC info@rowleylawpllc.com 914-400-1920 or 844-400-4643 (toll-free)

Proteostasis Therapeutics (NASDAQ:PTI)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Proteostasis Therapeutics Charts.
Proteostasis Therapeutics (NASDAQ:PTI)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Proteostasis Therapeutics Charts.